Genovac Purchases Third Beacon® Optofluidic System and Expands its Capabilities into Cell Line Development

Genovac Becomes the First Contract Research Organization (CRO) to Leverage the Beacon System for Both Antibody Discovery and Cell Line Development Genovac Becomes the First Contract Research Organization (CRO) to Leverage the Beacon System for Both Antibody Discovery and Cell Line Development

Read the original post:
Genovac Purchases Third Beacon® Optofluidic System and Expands its Capabilities into Cell Line Development

Related Posts